uniQure

uniQure N.V.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
37.14 M
Public Float
-
uniQure N.V.
Stock Exchange NASDAQ Stock Market
EPS
$2.48
Market Cap
$2.85 B
Shares Outstanding
37.63 M
Public Float
20.95 M

Profile

Address
Paasheuvelweg 25a
Amsterdam Noord-Holland 1105 BP
Netherlands
Employees -
Website http://www.uniqure.com
Updated 07/08/2019
uniQure NV engages in the research, development, and commercialization of gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded on January 9, 2012 and is headquartered in Amsterdam, the Netherlands.

Financials

View All

Matthew C. Kapusta
Director, Chief Executive & Financial Officer
David D. Meek
Director